National Institutes of Health: Immunologic Deficiency Syndromes trials
The registry lists 106 Immunologic Deficiency Syndromes studies with National Institutes of Health as lead sponsor. 16 are open to participants now and 10 have results posted.
Early Phase 1 1Phase 1 22Phase 2 21Phase 3 6Phase 4 3No phase 59(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionCompletedNCT00000638Not applicable
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionCompletedNCT00000636Not applicable
- Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency SyndromeCompletedNCT00000627Not applicable
- Viral Activation Transfusion Study (VATS)CompletedNCT00000593Not applicable
- Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)CompletedNCT00000590Phase 3
- Ganciclovir Implant Study for Cytomegalovirus RetinitisCompletedNCT00000118Phase 3